openPR Logo
Press release

Gastrointestinal OTC Drugs Market Growth & Revenue Opportunities by Top Key Players | Johnson & Johnson, GlaxoSmithKline, Bayer AG, Sanofi, Abbott Laboratories, Prestige Brands, Boehringer Ingelheim GmbH & Purdue Pharma L.P.

10-08-2018 05:48 PM CET | Health & Medicine

Press release from: Allied Market Research

Gastrointestinal OTC Drugs Market Growth & Revenue

Gastrointestinal diseases include complications related to the stomach, esophagus, large intestine, small intestine, gallbladder, rectum, liver, and pancreas. Gastrointestinal over the counter (OTC) drugs are medications that can be bought without any doctors prescription and are used to control vomiting, constipation, diarrhea, and flatulence.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-toc-and-sample/3531

The major factors that contribute to the growth of the gastrointestinal OTC drugs market include the increasing prevalence of gastrointestinal diseases, high adoption of OTC drugs as they are cost-effective & convenient to buy, advancements in R&D activities such as innovations in drugs, and high demand for self-diagnosis and self-medication. However, factors such as stringent government regulations and inadequate reimbursements provided for gastrointestinal OTC drugs hinder the market growth. Conversely, growth in public awareness and increase in healthcare expenditures are expected to provide numerous opportunities for the market growth in the near future.

The global gastrointestinal OTC drugs market is segmented on the basis of product, indication, end user, and region. On the basis of product, the market is segmented into laxatives, gastrointestinal cancer treatments, gastric acid reducers, anti-diarrheal, proton pump inhibitors, H2 inhibitors, gastric acid neutralizers, bowel anti-inflammatory, and anti-emetics. On the basis of indication, the market is segmented into gastroesophageal reflux disease (GERD) or heartburn, constipation, diarrhea, motion sickness, and flatulence. On the basis of end user, it is categorized into clinics, pharmacies, hospitals, and others. Geographically, the market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Get Customized Report @ https://www.alliedmarketresearch.com/request-for-customization/3531

The key players operate in this market include

- Johnson & Johnson,
- GlaxoSmithKline Plc.,
- Bayer AG,
- Sanofi,
- Abbott Laboratories,
- Pfizer Inc.,
- Prestige Brands, Inc.,
- Boehringer Ingelheim GmbH,
- Procter & Gamble, and Purdue Pharma L.P.

Key Benefits

- The study provides an in-depth analysis of the global gastrointestinal OTC drugs market with current trends and future estimations to elucidate imminent investment pockets.

- The report provides information about the current and upcoming trends in the global gastrointestinal OTC drugs market from 2016 to 2023, which helps determine prevailing opportunities.

- Comprehensive analysis of factors that drive and restrict the growth of the global gastrointestinal OTC drugs market has been provided.

- Identification of factors that are instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global and regional scale have been provided.

- Key market players within the market have been profiled in this report and their strategies thoroughly analyzed, which help understand the competitive outlook of the global gastrointestinal OTC drugs market.

For More Information @ https://www.alliedmarketresearch.com/purchase-enquiry/3531

Table Of Content


Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities

Access Full Summery @ https://www.alliedmarketresearch.com/gastrointestinal-OTC-drugs-market

About Us:

Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Gastrointestinal OTC Drugs Market Growth & Revenue Opportunities by Top Key Players | Johnson & Johnson, GlaxoSmithKline, Bayer AG, Sanofi, Abbott Laboratories, Prestige Brands, Boehringer Ingelheim GmbH & Purdue Pharma L.P. here

News-ID: 1288187 • Views:

More Releases from Allied Market Research

Emerging Technologies in Structural Steel Tube Market in Glob: Innovations and Future Prospects by 2033
Emerging Technologies in Structural Steel Tube Market in Glob: Innovations and F …
According to the report, "the structural steel tube market" was valued at $105.3 billion in 2023, and is estimated to reach $167.5 billion by 2033, growing at a CAGR of 4.8% from 2024 to 2033. Allied Market Research published a report, titled, "Structural Steel Tube Market By Type (Hot-Rolled Steel and Cold-Rolled Steel), Material (Stainless Steel Tube, Carbon Steel Tube, Alloy Steel Tube, and Others), Sales Type (Direct,
Costume Jewelry Market Size Worth USD 86.8 billion by 2033 | Growth Rate (CAGR) of 6.8%
Costume Jewelry Market Size Worth USD 86.8 billion by 2033 | Growth Rate (CAGR) …
According to a new report published by Allied Market Research, titled, "costume jewelry market" was valued at $45.2 billion in 2023, and is projected to reach $86.8 billion by 2033, growing at a CAGR of 6.8% from 2024 to 2033. Get Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/2093 Costume jewelry refers to decorative pieces made of inexpensive materials such as base metals, glass, plastic, or synthetic stones, often adorned with
Monoisopropanolamine Market: A Comprehensive Analysis of Trends, Growth and Opportunities, 2030 | AMR
Monoisopropanolamine Market: A Comprehensive Analysis of Trends, Growth and Oppo …
The global Monoisopropanolamine (MIPA) Market was pegged at $82.2 million in 2020, and is expected to reach $140.8 million by 2030, growing at a CAGR of 5.6% from 2021 to 2030. Allied Market Research recently published a report, titled, Monoisopropanolamine (MIPA) Market by End-use Industry (Chemical Industry, Personal Care, Agrochemical, Pharmaceuticals, Metalworking, and Others): Global Opportunity Analysis and Industry Forecast, 2021-2030". Download Sample Report with Statistical Info: https://www.alliedmarketresearch.com/request-sample/16048
Treadmill Market Navigating Business with CAGR of 5.1% with Revenue of $5,932.0 million by 2030
Treadmill Market Navigating Business with CAGR of 5.1% with Revenue of $5,932.0 …
The global treadmill market size was valued at $3,284.8 million in 2020, and is projected to reach $5,932.0 million by 2030, registering a CAGR of 5.1%. Request The Sample PDF Of This Report @ https://www.alliedmarketresearch.com/request-sample/4286 Treadmill is widely used for physical fitness equipment for weight management and improving body stamina & muscular strength. Mostly used treadmills are motorized or electronic, owing to advance features offered to users. Rise in

All 5 Releases


More Releases for OTC

Lawsuit filed for Investors who lost money with shares of adidas AG (OTC: ADDYY, …
An investor, who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF), filed a lawsuit over alleged violations of Federal Securities Laws by adidas AG in connection with certain allegedly false and misleading statements. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF) have certain options and for certain investors are short and strict deadlines running. Deadline: June 27, 2023. adidas AG (OTC: ADDYY, OTC: ADDDF) investors should contact
Investigation for Investors in adidas AG (OTC: ADDYY, OTC: ADDDF) announced over …
An investigation on behalf of investors in shares of adidas AG (OTC: ADDYY, OTC: ADDDF) was announced over potential breaches of fiduciary duties by certain officers and directors at adidas AG. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain adidas AG officers and
AMERICAN HEMP VENTURES INC (OTC: AMHV) TO BECOME YOUNEEQAI TECHNICAL SERVICES In …
FOR IMMEDIATE RELEASE Denver Colorado, March 31, 2023, American Hemp Ventures, Inc. (OTC: AMHV) announced today that its name has changed effective immediately to YouneeqAI Technical Services inc. (OTC: YQAI) reflecting the Company's new focus into cookie-less AI technology services. The current management team has over 50 years of experience in technology services and innovation. Murray Galbraith, YQAI's CEO, is the Founder of YouneeqAI's software solution and has operated several private technology
Investigation announced for Investors who lost money with shares of adidas AG (O …
An investigation was announced for investors of adidas AG (OTC: ADDYY, OTC: ADDDF) shares over potential securities laws violations by adidas AG. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of adidas AG (OTC: ADDYY,
Fuel Cell Market Technological Trends and Business Opportunities 2021 To 2026; P …
MarketInsightsReports has published a report titled global Fuel Cell Market research report 2021 that is a detailed observation of several aspects, including the rate of growth, technological advances, and different methodologies implemented by the primary current market players. The report is based on a collective analysis of data, which is obtained through primary and secondary research. It provides a systematic approach to the current and prospective scenario of this market. The
Deadline on Nov. 9th upcoming in Lawsuit for Investors in Harborside Inc. (OTC: …
The Shareholders Foundation announced that a deadline is coming up on November 9, 2020 in the lawsuit filed for certain investors of Harborside Inc. (OTC: HSDEF, OTC: HBORF). Investors who purchased shares of Harborside Inc. (OTC: HSDEF, OTC: HBORF) have certain options and there are strict and short deadlines running. Deadline: November 9, 2020. Harborside Inc. stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to